Electrocardiographic markers of proarrhythmogenicity in metabolic syndrome

Bulgarian Cardiology · Published 2025-05-12 · DOI 10.3897/bgcardio.31.e146569

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.3897/bgcardio.31.e146569

Abstract

The etiopathogenetic mechanisms of metabolic syndrome that affect cardiac electrophysiology and lead to myocardial remodelling are numerous. Cardiomyocyte changes induced by metabolic and proinflammatory factors impair repolarization, exacerbate the heterogeneity of the transmural dispersion of repolarization, and prolong the Tpeak-end interval. Tpeak-Tend interval has been described as a marker of arrhythmogenicity that is more sensitive than the standard QT interval. Multiple pathological conditions and their effect on myocardial repolarisation have been studied – coronary artery disease, sleep apnea, arterial hypertension, Brugada syndrome and other channelopathies, systemic sclerosis, endocrinological diseases such as hypothyroidism, diabetes mellitus, acromegaly, hypertrophic cardiomyopathy, sudden cardiac death, familial hypercholesterolemia, etc. Currently, the most widely accepted theory of the mechanism of formation of Tp-e the interval and its dynamics are transmural myocardial heterogeneity/dispersion repolarisation. For the clinician, this is an additional tool for assessment of arrhythmogenicity through easy and accessible electrocardiographic markers in daily clinical practice. There is very little literature data on the clinical application of electrocardiographic markers (Tp-e interval, Tp-e/QT ratio) for proarrhythmogenicity in patients with metabolic syndrome. Despite progress in the development of new cardiovascular diagnostic methods, electrocardiographic markers can help in daily clinical practice to add important prognostic information about proarrhythmogenicity.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2025

Related articles